671 related articles for article (PubMed ID: 27019627)
21. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and microRNA characterization of the neglected CD24+ cell population in MCF-7 breast cancer 3-dimensional spheroid culture.
Boo L; Yeap SK; Ali NM; Ho WY; Ky H; Satharasinghe DA; Liew WC; Tan SW; Wang ML; Cheong SK; Ong HK
J Chin Med Assoc; 2020 Jan; 83(1):67-76. PubMed ID: 31904742
[TBL] [Abstract][Full Text] [Related]
23. miR-145 overexpression triggers alteration of the whole transcriptome and inhibits breast cancer development.
Ye P; Shi Y; An N; Zhou Q; Guo J; Long X
Biomed Pharmacother; 2018 Apr; 100():72-82. PubMed ID: 29425746
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
25. miRNA expression profile in multicellular breast cancer spheroids.
Mandujano-Tinoco EA; Garcia-Venzor A; Muñoz-Galindo L; Lizarraga-Sanchez F; Favela-Orozco A; Chavez-Gutierrez E; Krötzsch E; Salgado RM; Melendez-Zajgla J; Maldonado V
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1642-1655. PubMed ID: 28576513
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
27. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
29. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
30. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
[TBL] [Abstract][Full Text] [Related]
31. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
32. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
[TBL] [Abstract][Full Text] [Related]
33. Polyphenol-Enriched Blueberry Preparation Controls Breast Cancer Stem Cells by Targeting FOXO1 and miR-145.
Mallet JF; Shahbazi R; Alsadi N; Matar C
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299605
[TBL] [Abstract][Full Text] [Related]
34. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
[TBL] [Abstract][Full Text] [Related]
35. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.
Bitarte N; Bandres E; Boni V; Zarate R; Rodriguez J; Gonzalez-Huarriz M; Lopez I; Javier Sola J; Alonso MM; Fortes P; Garcia-Foncillas J
Stem Cells; 2011 Nov; 29(11):1661-71. PubMed ID: 21948564
[TBL] [Abstract][Full Text] [Related]
38. Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines.
Guo J; He K; Zeng H; Shi Y; Ye P; Zhou Q; Pan Z; Long X
Oncol Lett; 2019 Apr; 17(4):3765-3776. PubMed ID: 30930984
[TBL] [Abstract][Full Text] [Related]
39. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
40. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.
Golestaneh AF; Atashi A; Langroudi L; Shafiee A; Ghaemi N; Soleimani M
Cell Biochem Funct; 2012 Jul; 30(5):411-8. PubMed ID: 22374783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
